The trading price of Asensus Surgical Inc (AMEX:ASXC) closed lower on Tuesday, April 23, closing at $0.25, -0.40% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $0.74 and a 52-week low of $0.20. Over the past month, the stock has gained 3.71% in value.
Asensus Surgical Inc, whose market valuation is $67.73 million at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -0.05 per share this quarter, however they have predicted annual earnings per share of -0.18 for current year and -0.14 for next year.
Analysts have forecast the company to bring in revenue of 1.2M for the current quarter, with the likely lows of 1.09M and highs of 1.3M. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 12.3M.
On the technical side, indicators suggest ASXC has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that ASXC’s price is currently -2.30% off the SMA20 and -10.35% off the SMA50. The RSI metric on the 14-day chart is currently showing 42.56, and weekly volatility stands at 4.47%. When measured over the past 30 days, the indicator reaches 6.54%. Asensus Surgical Inc (AMEX:ASXC)’s beta value is currently sitting at 1.44, while the Average True Range indicator is currently displaying 0.02.
To see how Asensus Surgical Inc stock has been performing in comparison to its peers in the industry, here are the numbers: ASXC stock’s performance was -0.40% in the latest trading, and -63.94% in the past year.
An evaluation of the daily trading volume of Asensus Surgical Inc (AMEX:ASXC) indicates that the 3-month average is 1.60 million.
Currently, records show that 271.99 million of the company’s shares remain outstanding. The insiders hold 1.95% of outstanding shares, whereas institutions hold 9.87%. However, since the stock’s price has seen -21.92% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
